Company profile for Aspargo Laboratories

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aspargo Laboratories commercialize rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible dose titration and accessibility for patients with dysphagia (trouble swallowing). Currently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy...
Aspargo Laboratories commercialize rights of an oral suspension spray formulation of erectile dysfunction medication Sildenafil citrate. Spray formulation offers convenient drug administration, flexible dose titration and accessibility for patients with dysphagia (trouble swallowing). Currently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia and China. Applications for approval are planned for Croatia, France, Germany and Austria.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
550 SYLVAN AVENUE, SUITE 102 ENGLEWOOD CLIFFS NJ 07632
Telephone
Telephone
201-408-4831
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/15/3061621/0/en/Aspargo-Labs-CEO-to-Participate-in-Panel-Discussion-at-the-American-Urological-Association-Innovation-Nexus-Conference.html

GLOBENEWSWIRE
15 Apr 2025

https://www.globenewswire.com/news-release/2025/04/07/3056653/0/en/Aspargo-Labs-Expands-Global-Leadership-Team.html

GLOBENEWSWIRE
07 Apr 2025

https://www.globenewswire.com/news-release/2025/02/26/3032848/0/en/Aspargo-Labs-Appoints-Mario-Guralnik-as-Chief-Regulatory-Officer.html

GLOBENEWSWIRE
26 Feb 2025

https://www.globenewswire.com/news-release/2025/01/27/3015526/0/en/Aspargo-Labs-Appoints-Harold-D-Tamayo-as-Chief-Financial-Officer.html

GLOBENEWSWIRE
27 Jan 2025

https://www.globenewswire.com/news-release/2024/12/20/3000570/0/en/Aspargo-Labs-Appoints-General-Managers-in-Spain-and-Germany-to-Drive-International-Expansion.html

GLOBENEWSWIRE
20 Dec 2024

https://www.globenewswire.com/news-release/2024/11/19/2983545/0/en/Aspargo-Labs-Appoints-Chief-Marketing-Officer.html

GLOBENEWSWIRE
19 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty